Roche Holding Ltd. (VTX:ROG)‘s stock had its “buy” rating reiterated by research analysts at J P Morgan Chase & Co in a research report issued on Monday.
A number of other equities research analysts also recently commented on the company. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on Roche Holding and gave the company a “buy” rating in a research report on Friday, May 26th. Citigroup Inc. reiterated a “buy” rating on shares of Roche Holding in a research report on Wednesday, July 5th. Morgan Stanley set a CHF 290 price objective on Roche Holding and gave the company a “buy” rating in a research report on Monday, May 29th. Deutsche Bank AG set a CHF 273 price objective on Roche Holding and gave the company a “buy” rating in a research report on Tuesday, June 6th. Finally, Societe Generale set a CHF 275 price objective on Roche Holding and gave the company a “neutral” rating in a research report on Thursday, June 29th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of CHF 271.21.
Roche Holding (ROG) opened at 241.40 on Monday. Roche Holding has a 52-week low of CHK 218.30 and a 52-week high of CHK 273.00. The firm’s 50-day moving average price is CHK 243.57 and its 200 day moving average price is CHK 252.51. The stock has a market cap of CHK 205.98 billion and a P/E ratio of 21.43.
TRADEMARK VIOLATION WARNING: “Roche Holding Ltd. (ROG) Receives Buy Rating from J P Morgan Chase & Co” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://sportsperspectives.com/2017/09/11/roche-holding-ltd-rog-receives-buy-rating-from-j-p-morgan-chase-co.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.